Mutual Of America Capital Management LLC Kodiak Sciences Inc. Transaction History

Mutual Of America Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$7.09 - $89.45 $264,797 - $3.34 Million	-37,348 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$80.85 - $128.49 $28,216 - $44,843	-349 Reduced 0.93%	37,348 $3.17 Million
Q3 2021 Nov 10, 2021	SELL	$81.97 - $106.94 $44,591 - $58,175	-544 Reduced 1.42%	37,697 $3.62 Million
Q2 2021 Aug 06, 2021	SELL	$77.2 - $126.54 $127,534 - $209,044	-1,652 Reduced 4.14%	38,241 $3.56 Million
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $242,658 - $361,340	-2,197 Reduced 5.22%	39,893 $4.52 Million
Q4 2020 Feb 12, 2021	SELL	$60.78 - $154.03 $56,039 - $142,015	-922 Reduced 2.14%	42,090 $6.18 Million
Q3 2020 Nov 13, 2020	SELL	$45.05 - $59.27 $333,460 - $438,716	-7,402 Reduced 14.68%	43,012 $2.55 Million
Q2 2020 Aug 06, 2020	BUY	$42.74 - $66.25 $1.2 Million - $1.86 Million	28,018 Added 125.1%	50,414 $2.73 Million
Q1 2020 May 11, 2020	BUY	$38.18 - $73.95 $855,079 - $1.66 Million	22,396 New	22,396 $1.07 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $423M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.